Scar Treatment Market Share, Size, Trends, Industry Analysis Report, 2024 - 2032
Scar Treatment Market Share, Size, Trends, Industry Analysis Report, 2024 - 2032

Scar Treatment Market Share, Size, Trends, Industry Analysis Report, By Product [Topical Products (Creams, Gels, Silicon Sheets, Others), Laser Products (CO2 Laser, Pulse-dyed Laser, Others), Injectables, Others], By Scar Type, By End-Use; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Jan-2024
  • Pages: 117
  • Format: PDF
  • Report ID: PM2136
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global scar treatment market size was valued at USD 2.63 billion in 2023. The market is anticipated to grow from USD 2.91 billion in 2024 to USD 6.67 billion by 2032, exhibiting the CAGR of 10.9% during the forecast period.

The rising market demand for scar treatment due to the increasing prevalence of various skin diseases and the increasing aesthetic sense of skin rejuvenation among the population is attributed to the global market growth. In addition, the rising disposable income coupled with growing responsiveness for the availability of the various wound treatments also acts as a catalyzing factor for the market demand.

Scar Treatment Market SizeKnow more about this reportrequest for sample pages

Moreover, increasing expenditures on the research & development activities for the growth of effective treatment and rising investment for the technological advancements by the chief players in the market are further major driving factors, which accelerate the scar treatment market demand over the coming years.

The market demand is impeded during this pandemic, thus leading to the downfall in the growth rate. The implementation of stringent lockdowns and social distancing norms across various regions exhibits the decreasing number of invasive and non-invasive procedures for wound treatment.

In addition, these lockdowns also affect the logistics and supply chain due to the unavailability of raw materials storage, which disrupts the production of goods. However, the market witnesses a noteworthy development in the approaching period owing to the gradual opening of the lockdown and resumption of the skin clinics, which, in turn, may bring an upsurge in the global wound treatment market in the future scenario.

Scar Treatment Market size

Industry Dynamics

Growth Drivers
The growing incidences of skin diseases are one of the significant driving factors that accelerate the market growth around the world. Several skin diseases such as photoaging, psoriasis, vitiligo, and eczema are major occur among the population because of extreme exposure to ultraviolet (UV) radiation and pollution. As a result, these factors may lead to reduced skin elasticity, hair loss, sunburns, etc.; consequently, these conditions that have not received any suitable treatment on time can lead to the formation of marks.

Numerous additional skin-related problems, such as post-surgical marks, acne, stretch marks due to pregnancy or changes in body weight, and burn marks, also lead to the development of marks. A large group of the population is majorly affected by acne a most common dermatological condition that eventually leads to the formation of marks. Thus, overcoming the harmful condition of these diseases leads to the adoption of scar treatment, which may attribute to the treatment market growth.

Report Segmentation

The market is primarily segmented on the basis of product, scar type, end-use, and region.

By Product

By Scar Type

By End-Use

By Region

  • Topical Products
    • Creams
    • Gels
    • Silicon Sheets
    • Others
  • Laser Products
    • CO2 Laser
    • Pulse-dyed Laser
    • Others
  • Injectables
  • Others
  • Atrophic Scars
  • Hypertrophic & Keloid Scars
  • Contracture Scars
  • Stretch Marks
  • Hospitals
  • Clinics
  • Retail Pharmacies/ E-commerce
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. Australia)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this reportrequest for sample pages

Insight by Scar Type

The atrophic scars segment is the leading segment in revenue generation in 2020 and is expected to dominate the treatment market over the coming years. Owing to the rising occurrence of acne scars, they are commonly cured by using gels and creams. These scars are generally caused by the fat and muscle loss from the individual’s body above the injured area. It is usually created when the skin makes inadequate collagen to repair the infection spot.

The treatments opted for these scars encourage the skin’s natural healing process to restore collagen, elastin, and other fibrous tissues. This allows the surface of the healed wound to develop around the contiguous area and reduces the visibility of marks. Accordingly, increasing market demand for aesthetic appeal fuels the need for topical products; this, in turn, leads to the dominance of the segment across the globe.

The hypertrophic & keloid scars segment is estimated to show substantial growth over the forecast period due to the rising incidences of wound injuries among the large group population. This hypertrophic scar is a thick elevated scar that is an unusual response to wound curative.

A keloid is caused by the overindulgence of a protein (collagen) in the skin during healing. They usually take place in stiff skin areas, subsequent surgical incisions, burns, or skin trauma. Thus, laser therapy for treating these marks is mainly preferred, and adoptions of silicone sheets are growing for healing hypertrophic & keloid marks. Hence, these factors exhibit segment growth over the forecast period.

Insight by End-Use

The hospital segment of the wound treatment industry is the largest revenue generator by holding the highest revenue shares in the global market. The presence of technologically advanced products and the availability of sophisticated infrastructure in these hospital settings leads to the dominance of the market.

The major accessibility for scar treatment in hospitals enables patients to select from an array of options to decrease or eradicate the wound. Hospitals also offer patients with primary emergency care in most cases, frequently dealing with cuts and wounds, burn injuries, and other severe injuries.

The treatment is also made available by hospitals to reduce additional mark formation on the patient's body. In addition, hospitals have a collection of technically advanced procedures and upgraded equipment for better patient care. The adoption of non-invasive procedures such as silicone sheets, creams, gels, and laser therapy is generally carried out at hospitals. Therefore, these various advantages offered by the hospitals largely contribute to segment growth.

The E-commerce segment has shown the highest CAGR over the forecast period due to factors' rapid development of online platforms and rising inclination towards online trading. Such platforms offer easy access to wound treatments on the company's websites, better convenience, fast & free delivery, discounts and rebates, and several offers. Thus, these benefits act as a catalyzing factor for market segment growth.

Scar Treatment Market seg

Geographic Overview

North America marks treatment is the most significant revenue contributor in 2020 and is expected to dominate the global market over the projected period. The growing market demand for the high aesthetic consciousness among the population and rapid penetration of the developed and innovative goods and services leads to the intensifying need for advanced laser instruments for scar treatment. The increasing incidence of burn injuries across the regions is propelling the adoption of the scar treatment market.

For instance, as per the American Burn Association (ABA) 2020 report, there are more than 450,000 serious burn injuries in the United States annually, which requires appropriate medical treatment. Moreover, several government reimbursement policies in the U.S. cover scar treatment that causes burn injuries, also scar treatment for acne may not be compensated until a healthcare specialist presents a Letter of Medical Necessity. Therefore, these factors create a productive market demand for scar treatment in North America.

Moreover, the Asia Pacific is projected to grow at the highest CAGR globally in the coming years. Owing to the factors such as the increasing number of road accidents majorly in the countries such as India, Afghanistan, China, as well as growing spending by the leading players for scar treatment development, creates a lucrative market demand of the treatment industry. In addition, the rising inclination of women towards aesthetic appeal has increased significantly along with the growing incidences of burn injuries and skin diseases.

Accordingly, these factors are fostering market growth across the Asia Pacific. Furthermore, increasing government expenditure on the development of the healthcare sector tied with the rising responsiveness about the availability of advanced treatments is further fueling the market growth in the Asia Pacific.

Scar Treatment Market reg

Competitive Insight

Some of the major players operating in the global market include Smith & Nephew PLC, Suneva Medical, Lumenis, CCA Industries, Inc., Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Sonoma Pharmaceuticals, Inc., Newmedical Technology Inc., and Cynosure.

Scar Treatment Market Report Scope

Report Attributes


Market size value in 2024

USD 2.91 billion

Revenue forecast in 2032

USD 6.67 billion


10.9% from 2024 - 2032

Base year


Historical data

2019 - 2022

Forecast period

2024 - 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 - 2032

Segments covered

By Product, By Scar Type, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Key companies

Smith & Nephew PLC, Suneva Medical, Lumenis, CCA Industries, Inc., Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Sonoma Pharmaceuticals, Inc., Newmedical Technology Inc., and Cynosure.